ICU Medical Inc. (NASDAQ:ICUI) – Roth Capital lifted their Q1 2017 EPS estimates for ICU Medical in a note issued to investors on Thursday. Roth Capital analyst C. Lewis now anticipates that the firm will post earnings per share of $1.07 for the quarter, up from their prior forecast of $0.99. Roth Capital also issued estimates for ICU Medical’s Q3 2017 earnings at $1.10 EPS.

A number of other brokerages have also issued reports on ICUI. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, November 2nd. Piper Jaffray Cos. reiterated a “neutral” rating and issued a $119.00 price target (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th.

Earnings History and Estimates for ICU Medical (NASDAQ:ICUI)

ICU Medical (NASDAQ:ICUI) opened at 144.30 on Monday. The stock has a 50 day moving average price of $139.49 and a 200 day moving average price of $119.72. ICU Medical has a 12-month low of $85.56 and a 12-month high of $154.80. The stock has a market cap of $2.34 billion, a P/E ratio of 41.61 and a beta of 0.30.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, November 9th. The company reported $1.35 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.17 by $0.18. The firm had revenue of $97.11 million for the quarter, compared to the consensus estimate of $93.04 million. ICU Medical had a return on equity of 10.70% and a net margin of 15.18%. The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.00 earnings per share.

In other ICU Medical news, VP Steven Riggs sold 44,739 shares of the stock in a transaction dated Tuesday, September 13th. The shares were sold at an average price of $121.78, for a total transaction of $5,448,315.42. Following the completion of the transaction, the vice president now owns 675 shares of the company’s stock, valued at approximately $82,201.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard Md Sherman sold 3,000 shares of the stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $122.51, for a total transaction of $367,530.00. Following the transaction, the director now directly owns 70,699 shares of the company’s stock, valued at approximately $8,661,334.49. The disclosure for this sale can be found here. 15.90% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC bought a new position in ICU Medical during the second quarter valued at approximately $124,000. Bank of Montreal Can bought a new position in ICU Medical during the second quarter valued at approximately $133,000. PineBridge Investments L.P. increased its position in ICU Medical by 3.6% in the second quarter. PineBridge Investments L.P. now owns 1,835 shares of the company’s stock valued at $207,000 after buying an additional 63 shares during the period. Amalgamated Bank bought a new position in ICU Medical during the second quarter valued at approximately $214,000. Finally, Violich Capital Management Inc. bought a new position in ICU Medical during the third quarter valued at approximately $214,000. 89.04% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

5 Day Chart for NASDAQ:ICUI

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.